Lupus Erythematosus, Systemic [clinicaltrials_resource:3a249c9ec668a1900613097b3b8531fc]
Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus [clinicaltrials:NCT00004643]Lupus Cohort--Thrombotic Events and Coronary Artery Disease [clinicaltrials:NCT00005436]High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide [clinicaltrials:NCT00005778]Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus [clinicaltrials:NCT00008749]Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome [clinicaltrials:NCT00025818]Anti-CD20 in Systemic Lupus Erythematosus [clinicaltrials:NCT00036491]clinicaltrials:NCT00065806clinicaltrials:NCT00071487clinicaltrials:NCT00076752clinicaltrials:NCT00089804clinicaltrials:NCT00094380Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) [clinicaltrials:NCT00113971]Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis [clinicaltrials:NCT00125307]clinicaltrials:NCT00137969Physical Therapy for Systemic Lupus Erythematosus (SLE) [clinicaltrials:NCT00152555]clinicaltrials:NCT00325741clinicaltrials:NCT00368264clinicaltrials:NCT00381810Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome [clinicaltrials:NCT00391924]clinicaltrials:NCT00392951European Society of Cutaneous Lupus Erythematosus (EUSCLE) [clinicaltrials:NCT00420121]Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus [clinicaltrials:NCT00563082]Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus [clinicaltrials:NCT00582465]Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00611663]clinicaltrials:NCT00714116clinicaltrials:NCT00774852Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment [clinicaltrials:NCT01060410]Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) [clinicaltrials:NCT01093911]clinicaltrials:NCT01127321clinicaltrials:NCT01257802Evaluation of the Influence of Food Regimen on Oshadi D Absorption [clinicaltrials:NCT01327352]Agricultural Health Study Follow-up [clinicaltrials:NCT01399411]Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus [clinicaltrials:NCT01405196]Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT01471301]Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis [clinicaltrials:NCT01582880]Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions [clinicaltrials:NCT01597050]Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE [clinicaltrials:NCT01702038]A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus [clinicaltrials:NCT01702740]An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of Systemic Lupus Erythematosus, in Adults [clinicaltrials:NCT01753193]Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT01764594]
condition [clinicaltrials_vocabulary:condition]
Prevention of Arthritis-Related Work Disability [clinicaltrials:NCT00000416]Psychoeducational Approach to Improve Health in Lupus [clinicaltrials:NCT00000417]Safety of Estrogens in Lupus: Hormone Replacement Therapy [clinicaltrials:NCT00000419]Safety of Estrogens in Lupus: Birth Control Pills [clinicaltrials:NCT00000420]clinicaltrials:NCT00000421Drug Therapy in Lupus Nephropathy [clinicaltrials:NCT00001212]Study of Systemic Lupus Erythematosus [clinicaltrials:NCT00001372]Cyclophosphamide and Fludarabine to Treat Lupus Nephritis [clinicaltrials:NCT00001676]A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus [clinicaltrials:NCT00001680]Ultraviolet Light Therapy for Systemic Lupus Erythematosus [clinicaltrials:NCT00004375]Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus [clinicaltrials:NCT00004643]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus [clinicaltrials:NCT00004662]Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus [clinicaltrials:NCT00004663]Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus [clinicaltrials:NCT00004665]Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus [clinicaltrials:NCT00004756]Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus [clinicaltrials:NCT00004795]Lupus Cohort--Thrombotic Events and Coronary Artery Disease [clinicaltrials:NCT00005436]High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide [clinicaltrials:NCT00005778]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus [clinicaltrials:NCT00006133]Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture [clinicaltrials:NCT00006134]Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus [clinicaltrials:NCT00008749]clinicaltrials:NCT00010335Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome [clinicaltrials:NCT00010400]Humanized LL2IGG to Treat Systemic Lupus Erythematosus [clinicaltrials:NCT00011908]Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00017641]Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome [clinicaltrials:NCT00025818]Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity [clinicaltrials:NCT00029926]Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease [clinicaltrials:NCT00035308]Anti-CD20 in Systemic Lupus Erythematosus [clinicaltrials:NCT00036491]Study of GL701 in Men With Systemic Lupus Erythematosus [clinicaltrials:NCT00037128]Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00042523]clinicaltrials:NCT00046774To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids [clinicaltrials:NCT00053560]Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) [clinicaltrials:NCT00054938]Study of Families With Twins or Siblings Discordant for Rheumatic Disorders [clinicaltrials:NCT00055055]clinicaltrials:NCT00065806Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases [clinicaltrials:NCT00069342]clinicaltrials:NCT00071175clinicaltrials:NCT00071487
condition browse [clinicaltrials_vocabulary:condition-browse]
Prevention of Arthritis-Related Work Disability [clinicaltrials:NCT00000416]Psychoeducational Approach to Improve Health in Lupus [clinicaltrials:NCT00000417]Safety of Estrogens in Lupus: Hormone Replacement Therapy [clinicaltrials:NCT00000419]Safety of Estrogens in Lupus: Birth Control Pills [clinicaltrials:NCT00000420]clinicaltrials:NCT00000421Drug Therapy in Lupus Nephropathy [clinicaltrials:NCT00001212]Study of Systemic Lupus Erythematosus [clinicaltrials:NCT00001372]Cyclophosphamide and Fludarabine to Treat Lupus Nephritis [clinicaltrials:NCT00001676]A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus [clinicaltrials:NCT00001680]Ultraviolet Light Therapy for Systemic Lupus Erythematosus [clinicaltrials:NCT00004375]Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus [clinicaltrials:NCT00004643]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus [clinicaltrials:NCT00004662]Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus [clinicaltrials:NCT00004663]Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus [clinicaltrials:NCT00004665]Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus [clinicaltrials:NCT00004756]Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus [clinicaltrials:NCT00004795]Lupus Cohort--Thrombotic Events and Coronary Artery Disease [clinicaltrials:NCT00005436]High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide [clinicaltrials:NCT00005778]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus [clinicaltrials:NCT00006133]Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture [clinicaltrials:NCT00006134]Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus [clinicaltrials:NCT00008749]clinicaltrials:NCT00010335Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome [clinicaltrials:NCT00010400]Humanized LL2IGG to Treat Systemic Lupus Erythematosus [clinicaltrials:NCT00011908]Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00017641]Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome [clinicaltrials:NCT00025818]Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity [clinicaltrials:NCT00029926]Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease [clinicaltrials:NCT00035308]Anti-CD20 in Systemic Lupus Erythematosus [clinicaltrials:NCT00036491]Study of GL701 in Men With Systemic Lupus Erythematosus [clinicaltrials:NCT00037128]Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00042523]clinicaltrials:NCT00046774To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids [clinicaltrials:NCT00053560]Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) [clinicaltrials:NCT00054938]Study of Families With Twins or Siblings Discordant for Rheumatic Disorders [clinicaltrials:NCT00055055]clinicaltrials:NCT00065806Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases [clinicaltrials:NCT00069342]clinicaltrials:NCT00071175clinicaltrials:NCT00071487
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Lupus Erythematosus, Systemic [clinicaltrials_resource:3a249c9ec668a1900613097b3b8531fc]
Bio2RDF identifier
3a249c9ec668a1900613097b3b8531fc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3a249c9ec668a1900613097b3b8531fc
identifier
clinicaltrials_resource:3a249c9ec668a1900613097b3b8531fc
title
Lupus Erythematosus, Systemic
@en
type
label
Lupus Erythematosus, Systemic [clinicaltrials_resource:3a249c9ec668a1900613097b3b8531fc]
@en
Lupus Erythematosus, Systemic